BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31404702)

  • 1. Thyroid disorders in patients with myasthenia gravis: A systematic review and meta-analysis.
    Song RH; Yao QM; Wang B; Li Q; Jia X; Zhang JA
    Autoimmun Rev; 2019 Oct; 18(10):102368. PubMed ID: 31404702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis.
    Song RH; Wang B; Yao QM; Li Q; Jia X; Zhang JA
    Front Immunol; 2019; 10():2349. PubMed ID: 31681268
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and risk of thyroid diseases in myasthenia gravis.
    Chou CC; Huang MH; Lan WC; Kong SS; Kuo CF; Chou IJ
    Acta Neurol Scand; 2020 Sep; 142(3):239-247. PubMed ID: 32329050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies.
    Taheriniya S; Arab A; Hadi A; Fadel A; Askari G
    BMC Endocr Disord; 2021 Aug; 21(1):171. PubMed ID: 34425794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyroid diseases and myasthenia gravis].
    De Assis JL; Scaff M; Zambon AA; Marchiori PE
    Arq Neuropsiquiatr; 1984 Sep; 42(3):226-31. PubMed ID: 6497714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis.
    Luo W; Mao P; Zhang L; Yang Z
    Lupus; 2018 Nov; 27(13):2120-2128. PubMed ID: 30376437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.
    Salari N; Fatahi B; Bartina Y; Kazeminia M; Fatahian R; Mohammadi P; Shohaimi S; Mohammadi M
    J Transl Med; 2021 Dec; 19(1):516. PubMed ID: 34930325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Thyroid Disorders in Patients With Vitiligo: A Systematic Review and Meta-Analysis.
    Yuan J; Sun C; Jiang S; Lu Y; Zhang Y; Gao XH; Wu Y; Chen HD
    Front Endocrinol (Lausanne); 2018; 9():803. PubMed ID: 30697190
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and meta-analysis.
    Pan XF; Gu JQ; Shan ZY
    Endocrine; 2015 Sep; 50(1):79-86. PubMed ID: 25645464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000-2022: a systematic review and meta-analysis.
    Hadgu R; Worede A; Ambachew S
    Syst Rev; 2024 Apr; 13(1):119. PubMed ID: 38689302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of myasthenia gravis with thyroid disease with 106 patients].
    Meng C; Jing Y; Li R; Zhang X; Wang J
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):854-8. PubMed ID: 27045646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis.
    Pan XF; Gu JQ; Shan ZY
    PLoS One; 2015; 10(4):e0123291. PubMed ID: 25905898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia.
    Xu J; Wang B; Li Q; Yao Q; Jia X; Song R; Zhang JA
    Horm Metab Res; 2019 Aug; 51(8):522-530. PubMed ID: 31408898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis.
    Ashrafi S; Hatami H; Bidhendi-Yarandi R; Panahi MH
    BMC Endocr Disord; 2024 Jan; 24(1):5. PubMed ID: 38166835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complicating autoimmune diseases in myasthenia gravis: a review.
    Nacu A; Andersen JB; Lisnic V; Owe JF; Gilhus NE
    Autoimmunity; 2015; 48(6):362-8. PubMed ID: 25915571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.
    Fang Y; Yao L; Sun J; Yang R; Chen Y; Tian J; Yang K; Tian L
    J Endocrinol Invest; 2017 Oct; 40(10):1035-1047. PubMed ID: 28516372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional chemosensation in myasthenia gravis: a systematic review.
    Leon-Sarmiento FE; Leon-Ariza DS; Doty RL
    J Clin Neuromuscul Dis; 2013 Sep; 15(1):1-6. PubMed ID: 23965402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some syndromes accompanying thyroid diseases; myasthenia, persistent thymus, thyroid crisis].
    HARTWIG W
    Pol Arch Med Wewn; 1956; 26(1):67-76. PubMed ID: 13335573
    [No Abstract]   [Full Text] [Related]  

  • 19. PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis.
    Xiong X; Xiang M; Cheng X; Huang Y
    Med Sci Monit; 2015 Aug; 21():2567-71. PubMed ID: 26318187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Yan Z; Huang H; Li J; Wang J
    Osteoporos Int; 2016 Jan; 27(1):115-25. PubMed ID: 26223189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.